Riemann L, Gutierrez R, Odak I, Barros-Martins J, Roesner L, Leon Lara X
EBioMedicine. 2025; 112:105558.
PMID: 39862806
PMC: 11873576.
DOI: 10.1016/j.ebiom.2025.105558.
Ieven T, Goossens J, Roosens W, Jonckheere A, Cremer J, Dilissen E
Front Immunol. 2024; 15:1506034.
PMID: 39737168
PMC: 11683848.
DOI: 10.3389/fimmu.2024.1506034.
Tam I, Lee T, Lau H, Tam S
Cells. 2024; 13(15.
PMID: 39120269
PMC: 11311466.
DOI: 10.3390/cells13151237.
Schulman E, Nishi H, Pelleg A
Front Immunol. 2023; 14:1216580.
PMID: 37868982
PMC: 10585249.
DOI: 10.3389/fimmu.2023.1216580.
Omar Osman I, Mezouar S, Brahim-Belhaouari D, Mege J, Devaux C
PLoS One. 2023; 18(6):e0285577.
PMID: 37285354
PMC: 10246793.
DOI: 10.1371/journal.pone.0285577.
Discovery of an agonistic Siglec-6 antibody that inhibits and reduces human mast cells.
Schanin J, Korver W, Brock E, Leung J, Benet Z, Luu T
Commun Biol. 2022; 5(1):1226.
PMID: 36369358
PMC: 9652399.
DOI: 10.1038/s42003-022-04207-w.
Utilizing mast cells in a positive manner to overcome inflammatory and allergic diseases.
Zhang Z, Ernst P, Kiyono H, Kurashima Y
Front Immunol. 2022; 13:937120.
PMID: 36189267
PMC: 9518231.
DOI: 10.3389/fimmu.2022.937120.
Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells.
Robida P, Rische C, Ben-Baruch Morgenstern N, Janarthanam R, Cao Y, Krier-Burris R
Cells. 2022; 11(7).
PMID: 35406705
PMC: 8997871.
DOI: 10.3390/cells11071138.
Mechanisms and biomarkers of inflammatory endotypes in chronic rhinosinusitis without nasal polyps.
Klingler A, Stevens W, Tan B, Peters A, Poposki J, Grammer L
J Allergy Clin Immunol. 2020; 147(4):1306-1317.
PMID: 33326802
PMC: 8216505.
DOI: 10.1016/j.jaci.2020.11.037.
A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation.
Schanin J, Gebremeskel S, Korver W, Falahati R, Butuci M, Haw T
Mucosal Immunol. 2020; 14(2):366-376.
PMID: 32814824
PMC: 7946634.
DOI: 10.1038/s41385-020-00336-9.
Mast Cell Activation Test (MAT).
Bahri R, Bulfone-Paus S
Methods Mol Biol. 2020; 2163:227-238.
PMID: 32766980
DOI: 10.1007/978-1-0716-0696-4_19.
Rapid identification of human mast cell degranulation regulators using functional genomics coupled to high-resolution confocal microscopy.
Folkerts J, Gaudenzio N, Maurer M, Hendriks R, Stadhouders R, Tam S
Nat Protoc. 2020; 15(3):1285-1310.
PMID: 32060492
PMC: 7197894.
DOI: 10.1038/s41596-019-0288-6.
Rapid Mast Cell Generation from Gata2 Reporter Pluripotent Stem Cells.
Kauts M, De Leo B, Rodriguez-Seoane C, Ronn R, Glykofrydis F, Maglitto A
Stem Cell Reports. 2018; 11(4):1009-1020.
PMID: 30197119
PMC: 6178197.
DOI: 10.1016/j.stemcr.2018.08.007.
Mast cell activation test in the diagnosis of allergic disease and anaphylaxis.
Bahri R, Custovic A, Korosec P, Tsoumani M, Barron M, Wu J
J Allergy Clin Immunol. 2018; 142(2):485-496.e16.
PMID: 29518421
PMC: 6075471.
DOI: 10.1016/j.jaci.2018.01.043.
An optimized protocol for the generation and functional analysis of human mast cells from CD34 enriched cell populations.
Yin Y, Bai Y, Olivera A, Desai A, Metcalfe D
J Immunol Methods. 2017; 448:105-111.
PMID: 28629733
PMC: 5654741.
DOI: 10.1016/j.jim.2017.06.003.
A randomized controlled phase II clinical trial comparing ONO-4053, a novel DP1 antagonist, with a leukotriene receptor antagonist pranlukast in patients with seasonal allergic rhinitis.
Okubo K, Hashiguchi K, Takeda T, Baba K, Kitagoh H, Miho H
Allergy. 2017; 72(10):1565-1575.
PMID: 28378369
PMC: 5638107.
DOI: 10.1111/all.13174.
CEACAM1 long isoform has opposite effects on the growth of human mastocytosis and medullary thyroid carcinoma cells.
Ueshima C, Kataoka T, Takei Y, Hirata M, Sugimoto A, Hirokawa M
Cancer Med. 2017; 6(4):845-856.
PMID: 28332308
PMC: 5387134.
DOI: 10.1002/cam4.1050.
KTN0158, a Humanized Anti-KIT Monoclonal Antibody, Demonstrates Biologic Activity against both Normal and Malignant Canine Mast Cells.
London C, Gardner H, Rippy S, Post G, La Perle K, Crew L
Clin Cancer Res. 2016; 23(10):2565-2574.
PMID: 27815356
PMC: 5418113.
DOI: 10.1158/1078-0432.CCR-16-2152.
Novel six-week protocol for generating functional human connective tissue-type (MC) mast cells from buffy coats.
Tam I, Ng C, Tam S, Lau H
Inflamm Res. 2016; 66(1):25-37.
PMID: 27628164
DOI: 10.1007/s00011-016-0989-z.
Carbonic anhydrase enzymes regulate mast cell-mediated inflammation.
Henry E, Sy C, Inclan-Rico J, Espinosa V, Ghanny S, Dwyer D
J Exp Med. 2016; 213(9):1663-73.
PMID: 27526715
PMC: 4995079.
DOI: 10.1084/jem.20151739.